Correction: Phenylboronic acid-modified nanoparticles for cancer treatment
Abstract
Correction for ‘Phenylboronic acid-modified nanoparticles for cancer treatment’ by Siming Zhou et al., Chem. Commun., 2025, 61, 4595–4605, DOI: 10.1039/D4CC06730D.
We are excited to let you know that our journals content will be migrating to the Silverchair platform on the 30th June 2026.
All of our content will still be hosted at pubs.rsc.org and the new platform will provide a more intuitive reading and navigation experience, along with improved discovery and indexing of your work.
Please be aware that the site will be temporarily unavailable on the 30th June to support the migration to the new platform. If you are unable to access the platform on the day, please try again later.
We look forward to seeing you on the new platform!
* Corresponding authors
a
Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China
E-mail:
zhiyongqian@scu.edu.cn
b
Department of Nuclear Medicine, Laboratory of Clinical Nuclear Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China
E-mail:
shengh1990@126.com
Correction for ‘Phenylboronic acid-modified nanoparticles for cancer treatment’ by Siming Zhou et al., Chem. Commun., 2025, 61, 4595–4605, DOI: 10.1039/D4CC06730D.
Please wait while we load your content...
Something went wrong. Try again?
S. Zhou, L. Dai, L. Pan, G. Shen and Z. Qian, Chem. Commun., 2026, 62, 12188 DOI: 10.1039/D6CC90175A
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content